LBRX SCHEDULE 13G/A: SEC filing

TCG Crossover Fund II, L.P. and related reporting persons

Filed with the SEC on · accession 0001193125-26-464051

LBRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. TCG Crossover Fund II, L.P. and related reporting persons filed Amendment No. 3 to their Schedule 13G, reporting beneficial ownership of 765,050 shares, or 2.4%, of LB Pharmaceuticals Inc. common stock as of September 30, 2026. The stock moved -0.0% by the first close after the filing.

Summary of the filing

TCG Crossover Fund II, L.P. and related reporting persons filed Amendment No. 3 to their Schedule 13G, reporting beneficial ownership of 765,050 shares, or 2.4%, of LB Pharmaceuticals Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

Key details

Shares beneficially owned$765K
Percent of class ownedPCT 2
Shares outstanding as of November 3, 2026$32.4M
Reporting person / beneficial ownerTCG Crossover Fund II, L.P.
General partner of tcg crossover fund ii, l.p.TCG Crossover GP II, LLC
IssuerLB Pharmaceuticals Inc.
Sole managing member of tcg crossover gp ii, llcChen Yu
Authorized signatoryCraig Skaling

How LBRX stock reacted

Close before

$43.01

Nov 13, 2026

First close after

-0.05%

$42.99

5 trading days

—

Since filing

-6.30%

$40.30

✦ Ask GOAX AI about this filing — what it means for LBRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LBRX?

Click here

Frequently asked questions

What did LBRX file with the SEC on Nov 16, 2026?

LBRX filed a SCHEDULE 13G/A (SEC filing). TCG Crossover Fund II, L.P. and related reporting persons filed Amendment No. 3 to their Schedule 13G, reporting beneficial ownership of 765,050 shares, or 2.4%, of LB Pharmaceuticals Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did LBRX stock react to this filing?

LBRX closed at $43.01 before the filing and $42.99 on Nov 16, 2026 (-0.05%).

Other LBRX SEC filings

Get alerts when LBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days